Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07303816) titled 'Statins to Prevent Cancer Associated Blood Clots' on Dec. 23, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Triple (Participant, Care Provider, Investigator).
Primary Sponsor: Brigham and Women's Hospital
Condition:
Venous Thromboembolism
Cancer
Cardiovascular Events
Intervention:
Drug: Rosuvastatin
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: April 1, 2026
Target Sample Size: 4000
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/s...